2′-C-cyano-2′-deoxy-1-β-D-arabino-pentofuranosylcytosine:: A novel anticancer nucleoside analog that causes both DNA strand breaks and G2 arrest

被引:65
作者
Azuma, A
Huang, P
Matsuda, A
Plunkett, W
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA
[2] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido 060, Japan
关键词
D O I
10.1124/mol.59.4.725
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The mechanism of 2'-C-cyano-2'-deoxy-1-beta -D-arabino-pentofuranosylcytosine (CNDAC) action was investigated in human lymphoblastoid CEM cells and myeloblastic leukemia ML-1 cells. CNDAC was metabolized to its 5'-triphosphate and incorporated into DNA, which was associated with inhibition of DNA synthesis. After incubation of cells with [H-3]CNDAC, metabolites were detected in 3'-->5' phosphodiester linkage and at the 3' terminus of cellular DNA. Specific enzymatic hydrolysis of DNA demonstrated that the parent nucleoside and its 2'-epimer 2'-C-cyano-2'-deoxy-2-ribo-pentofuranosylcytosine accounted for approximately 65% of the total analogs incorporated into DNA and essentially all of the drug in the 3'-->5' phosphodiester linkage. In contrast, all detectable radioactivity at 3' termini was associated with 2'-C-cyano-2',3'-didehydro-2',3'-dideoxycytidine. This de facto DNA chain-terminating nucleotide arises from an electronic characteristic and cleavage of the 3'-phosphodiester bond subsequent to the addition of a nucleotide to the incorporated CNDAC moiety by beta -elimination, a process that generates a single strand break in DNA. Investigation of the biological consequences of these actions indicated that, after incubation with cytostatic concentrations of CNDAC, cell cycle progression was delayed during S phase, but that cells arrested predominantly in the G(2) phase. This differed from the S phase-arresting actions of ara-C and gemcitabine, other deoxycytidine analogs that inhibit DNA replication but do not cause strand breaks. Thus, once incorporated into DNA, the CNDAC molecule appears to act by a dual mechanism that 1) delays the progress of further DNA replication, but 2) upon addition of a deoxynucleotide results in the conversion of the incorporated analog to a de facto DNA chain terminator at the 3' terminus of a single strand break. It is likely that DNA strand breaks trigger cell cycle arrest in G(2).
引用
收藏
页码:725 / 731
页数:7
相关论文
共 34 条
[1]   NUCLEOSIDES AND NUCLEOTIDES .141. CHEMICAL-STABILITY OF A NEW ANTITUMOR NUCLEOSIDE, 2'-C-CYANO-2'-DEOXY-1-BETA-D-ARABINO-PENTOFURANOSYLCYTOSINE IN ALKALINE-MEDIUM - FORMATION OF 2'-C-CYANO-2'-DEOXY-1-BETA-D-RIBO-PENTOFURANOSYLCYTOSINE AND ITS ANTITUMOR-ACTIVITY [J].
AZUMA, A ;
HANAOKA, K ;
KURIHARA, A ;
KOBAYASHI, T ;
MIYAUCHI, S ;
KAMO, N ;
TANAKA, M ;
SASAKI, T ;
MATSUDA, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (17) :3391-3397
[2]   NUCLEOSIDES AND NUCLEOTIDES .122. 2'-C-CYANO-2'-DEOXY-1-BETA-D-ARABINOFURANOSYLCYTOSINE AND ITS DERIVATIVES - A NEW CLASS OF NUCLEOSIDE WITH A BROAD ANTITUMOR SPECTRUM [J].
AZUMA, A ;
NAKAJIMA, Y ;
NISHIZONO, N ;
MINAKAWA, N ;
SUZUKI, M ;
HANAOKA, K ;
KOBAYASHI, T ;
TANAKA, M ;
SASAKI, T ;
MATSUDA, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (26) :4183-4189
[3]  
AZUMA A, 1908, IN PRESS BIOCH PHARM
[4]   THE FISSION YEAST CDC2 CDC13 SUC1 PROTEIN-KINASE - REGULATION OF CATALYTIC ACTIVITY AND NUCLEAR-LOCALIZATION [J].
BOOHER, RN ;
ALFA, CE ;
HYAMS, JS ;
BEACH, DH .
CELL, 1989, 58 (03) :485-497
[5]   ACTIVITY OF HUMAN DNA POLYMERASE-ALPHA AND POLYMERASE-BETA WITH 2-CHLORO-2'-DEOXYADENOSINE 5'-TRIPHOSPHATE AS A SUBSTRATE AND QUANTITATIVE EFFECTS OF INCORPORATION ON CHAIN EXTENSION [J].
CHUNDURU, SK ;
APPLEMAN, JR ;
BLAKLEY, RL .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1993, 302 (01) :19-30
[6]   CRYSTAL-STRUCTURE OF CYCLIN-DEPENDENT KINASE-2 [J].
DEBONDT, HL ;
ROSENBLATT, J ;
JANCARIK, J ;
JONES, HD ;
MORGAN, DO ;
KIM, SH .
NATURE, 1993, 363 (6430) :595-602
[7]  
DONEHOWER RC, 2000, P AN M AM SOC CLIN, V19, pA196
[8]  
Estey E, 1996, LEUKEMIA, V10, P932
[9]   CYCLIN-B IN XENOPUS OOCYTES - IMPLICATIONS FOR THE MECHANISM OF PRE-MPF ACTIVATION [J].
GAUTIER, J ;
MALLER, JL .
EMBO JOURNAL, 1991, 10 (01) :177-182
[10]  
Hanaoka K, 1999, INT J CANCER, V82, P226, DOI 10.1002/(SICI)1097-0215(19990719)82:2<226::AID-IJC13>3.0.CO